Hint mode is switched on Switch off

ADMA Biologics, ordinary share
ADMA, US0008991046

Add a stock to WL
Choose all Reset all
ADMA Biologics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    ADMA Biologics Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ADMA
  • Placement
    13.03.2015
  • Lock up period
    180
  • Number of papers
    1,225,000
  • Volume of raised funds
    9.8 mln USD
  • Placement share
    11.65%
  • Final placement price
    8 USD
  • Price change since placement date
    -0.38%
  • By capitalization
    84.13 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ADMA
  • Placement
    09.11.2017
  • Lock up period
    180
  • Number of papers
    16,976,744
  • Volume of raised funds
    36.5 mln USD
  • Placement share
    39.69%
  • Final placement price
    2.15 USD
  • Price change since placement date
    270.7%
  • By capitalization
    91.96 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ADMA
  • Placement
    08.06.2018
  • Lock up period
    180
  • Number of papers
    8,368,200
  • Volume of raised funds
    40 mln USD
  • Placement share
    18.56%
  • Final placement price
    4.78 USD
  • Price change since placement date
    66.74%
  • By capitalization
    215.55 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ADMA
  • Placement
    07.02.2020
  • Lock up period
    180
  • Number of papers
    23,500,000
  • Volume of raised funds
    82.25 mln USD
  • Placement share
    28.38%
  • Final placement price
    3.5 USD
  • Price change since placement date
    127.71%
  • By capitalization
    289.86 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ADMA
  • Placement
    21.10.2021
  • Lock up period
    180
  • Number of papers
    50,000,000
  • Volume of raised funds
    50 mln USD
  • Placement share
    27.49%
  • Final placement price
    1 USD
  • Price change since placement date
    697%
  • By capitalization
    181.87 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Related Stock indices

Indicators

News

27/03/2026 ADMA Biologics: Regulation Fd Disclosure, Exhibits
02/03/2026 ADMA Biologics: Regulation Fd Disclosure, Other Events, Exhibits
12/01/2026 ADMA Biologics: Results Of Operations And Financial Condition, Regulation Fd, Exhibits
05/08/2025 ADMA Biologics: Entry Into A Material Definitive Agreement, Termination Of A Material Definitive Agreement, Results Of Operations And Financial Condition, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Exhibits
04/06/2025 ADMA Biologics: Submission Of Matters To A Vote Of Security Holders
All organization news

Holders

Industry Leaders

Registration is required to get access.